Najib Rahman
Pleural disease
The Oxford Centre for Respiratory Medicine has been foremost in the UK in advancing the understanding of pleural disease such as empyema, malignant pleural effusions and pneumothorax. The thrust of its research has been mainly clinical and designed to answer important clinical questions. Recent advances in this area include the use of fibrinolytics in the management of empyema and malignant effusions, safety and efficacy of pleurodesis agents, and identification of organisms responsible for empyema. The unit runs ultrasound and thoracoscopy courses.
Recent publications
The feasibility and acceptability of conducting a randomised controlled trial evaluating a healthcare professional-supported, self-management intervention for people suffering from fatigue after critical illness
Journal article
Yu Y. et al, (2026), Pilot and Feasibility Studies, 12
Global trends in pleural infection mortality: a WHO-mortality database analysis
Journal article
Gonnelli F. et al, (2026), ERJ Open Research, 00551 - 2026
Qualitative insights into patient and carer perspectives of malignant pleural effusion management: an embedded study within the TACTIC trial
Journal article
Milne A. et al, (2026), BMJ Open Respiratory Research, 13
Pleural Management Pathways and Outcomes in Haematological Malignancy-Associated Malignant Pleural Effusion
Journal article
Walsh O. et al, (2026), Journal of Clinical Medicine, 15
Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study
Journal article
Gardiner LE. et al, (2026), International Journal of Infectious Diseases, 168
